mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.08 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.08 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.08 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.08 |
mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
0.077 |
0.08 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.08 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.08 |